4//SEC Filing
Wallace Max N. 4
Accession 0001104659-21-126701
CIK 0001818382other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 3:31 PM ET
Size
5.4 KB
Accession
0001104659-21-126701
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Wallace Max N.
Director
Transactions
- Award
Stock Options (right to buy)
2021-10-13+8,500→ 8,500 totalExercise: $10.03Exp: 2031-10-13→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on October 13, 2022, after which 1/36 of the option will become exercisable on the 13th of each month through October 13, 2025.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001877453
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 3:31 PM ET
- Size
- 5.4 KB